Cargando…
Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19 associated rhino-orbito-cerebral mucormycosis: A prospective cohort study
OBJECTIVE: To evaluate the efficacy and safety of short-course intravenous amphotericin B followed by sustained release posaconazole tablets for diabetes or COVID-19 associated rhino-orbito-cerebral mucormycosis (ROCM). METHODS: This prospective, pragmatic study included adults with diabetes or COVI...
Autores principales: | Manesh, Abi, Devasagayam, Emily, Bhanuprasad, Kundakarla, Varghese, Lalee, Kurien, Regi, Cherian, Lisa M., Dayanand, Divya, George, Mithun M., Kumar, Selwyn S., Karthik, Rajiv, Vanjare, Harshad, Peter, Jayanthi, Michael, Joy S., Thomas, Meera, Mathew, Binu S., Samuel, Prasanna, Peerawaranun, Pimnara, Mukaka, Mavuto, Rupa, Vedantam, Varghese, George M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281032/ https://www.ncbi.nlm.nih.gov/pubmed/37348653 http://dx.doi.org/10.1016/j.cmi.2023.06.017 |
Ejemplares similares
-
Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic
por: Bhanuprasad, Kundakarla, et al.
Publicado: (2021) -
Whole genome analysis of Rhizopus species causing rhino-cerebral mucormycosis during the COVID-19 pandemic
por: Michael, Joy Sarojini, et al.
Publicado: (2023) -
Community seroprevalence and risk factors for SARS-CoV-2 infection in different subpopulations in Vellore, India, and their implications for future prevention
por: Dayanand, Divya, et al.
Publicado: (2022) -
Rhino-orbito-cerebral mucormycosis
por: Raymundo, Igor Teixeira, et al.
Publicado: (2015) -
La mucormycose rhino-orbito-cérébrale
por: Derkaoui, Ali, et al.
Publicado: (2012)